PARAMETERS OF DAILY BLOOD PRESSURE MONITORING AND SERUM LEVELS OF CHEMERIN AND NESFATIN-1 IN HYPERTENSIVE PATIENTS WITH OBESITY


  • S.V. Ivanchenko Kharkiv National Medical University, Ukraine
Keywords: adipokines, metabolic syndrome, cardiovascular risk

Abstract

PARAMETERS OF DAILY BLOOD PRESSURE MONITORING AND SERUM LEVELS OF CHEMERIN AND NESFATIN-1 IN HYPERTENSIVE PATIENTS WITH OBESITY

References

1. Seven E. An overweight, hypertension and cardiovascular disease: focus on adipocytokines, insulin, weight changes, and natriuretic peptides. Dan Med J. Nov. 2015; 62 (11): B5163.

2. Kaur J, Mattu HS, Chatha K, Randeva HS. Chemerin in human cardiovascular disease. Vascul Pharmacol. Nov. 2018; 110: 1-6. do: 10.1016 / j.vph.2018.06.018.

3. Ramesh N, Gawli K, Pasupulleti VK, Unniappan S. Metabolic and Cardiovascular Actions of Nesfatin-1: Implications in Health and Disease. Curr Pharm Des. 2017; 23 (10): 1453-1464. do: 10.2174 / 1381612823666170130154407.
Published
2018-11-15
How to Cite
Ivanchenko, S. (2018). PARAMETERS OF DAILY BLOOD PRESSURE MONITORING AND SERUM LEVELS OF CHEMERIN AND NESFATIN-1 IN HYPERTENSIVE PATIENTS WITH OBESITY. Biological Markers in Fundamental and Clinical Medicine (scientific Journal), 2(2), 28-29. https://doi.org/10.29256/v.02.02.2018.escbm21
Section
Selected abstracts